Background: Although Bismuth-Corlette (BC) type 4 perihilar cholangiocarcinoma (pCCA) is no longer considered a contraindication for curative surgery, few data are available from Western series to indicate the outcomes for these patients. This study aimed to compare the short- and long-term outcomes for patients with BC type 4 versus BC types 2 and 3 pCCA undergoing surgical resection using a multi-institutional international database. Methods: Uni- and multivariable analyses of patients undergoing surgery at 20 Western centers for BC types 2 and 3 pCCA and BC type 4 pCCA. Results: Among 1138 pCCA patients included in the study, 826 (73%) had BC type 2 or 3 disease and 312 (27%) had type 4 disease. The two groups demonstrated significant differences in terms of clinicopathologic characteristics (i.e., portal vein embolization, extended hepatectomy, and positive margin). The incidence of severe complications was 46% for the BC types 2 and 3 patients and 51% for the BC type 4 patients (p = 0.1). Moreover, the 90-day mortality was 13% for the BC types 2 and 3 patients and 12% for the BC type 4 patients (p = 0.57). Lymph-node metastasis (N1; hazard-ratio [HR], 1.62), positive margins (R1; HR, 1.36), perineural invasion (HR, 1.53), and poor grade of differentiation (HR, 1.25) were predictors of survival (all p ≤0.004), but BC type was not associated with prognosis. Among the N0 and R0 patients, the 5-year overall survival was 43% for the patients with BC types 2 and 3 pCCA and 41% for those with BC type 4 pCCA (p = 0.60). Conclusions: In this analysis of a large Western multi-institutional cohort, resection was shown to be an acceptable curative treatment option for selected patients with BC type 4 pCCA although a more technically challenging surgical approach was required.

Surgery for Bismuth-Corlette Type 4 Perihilar Cholangiocarcinoma : Results from a Western Multicenter Collaborative Group / A. Ruzzenente, F. Bagante, P.B. Olthof, L. Aldrighetti, R. Alikhanov, M. Cescon, B.G. Koerkamp, W.R. Jarnagin, S. Nadalin, J. Pratschke, M. Schmelzle, E. Sparrelid, H. Lang, C. Iacono, T.M. van Gulik, A. Guglielmi, A. Andreou, F. Bartsch, C. Benzing, S. Buettner, T. Campagnaro, I. Capobianco, R. Charco, P. de Reuver, E. de Savornin Lohman, C.H.C. Dejong, M. Efanov, J.I. Erdmann, L.C. Franken, G. Giovinazzo, M.C. Giglio, C. Gomez-Gavara, F. Heid, J.N.M. IJzermans, J. Isaac, H. Jansson, M.A.P. Ligthart, S.K. Maithel, M. Malago, H.Z. Malik, P. Muiesan, S.W.M.O. Damink, L.M. Quinn, F. Ratti, M. Ravaioli, J. Rolinger, E. Schadde, M. Serenari, R. Troisi, S. van Laarhoven, J.L.A. van Vugt. - In: ANNALS OF SURGICAL ONCOLOGY. - ISSN 1068-9265. - 28:12(2021), pp. 7719-7729. [10.1245/s10434-021-09905-z]

Surgery for Bismuth-Corlette Type 4 Perihilar Cholangiocarcinoma : Results from a Western Multicenter Collaborative Group

P. Muiesan;
2021

Abstract

Background: Although Bismuth-Corlette (BC) type 4 perihilar cholangiocarcinoma (pCCA) is no longer considered a contraindication for curative surgery, few data are available from Western series to indicate the outcomes for these patients. This study aimed to compare the short- and long-term outcomes for patients with BC type 4 versus BC types 2 and 3 pCCA undergoing surgical resection using a multi-institutional international database. Methods: Uni- and multivariable analyses of patients undergoing surgery at 20 Western centers for BC types 2 and 3 pCCA and BC type 4 pCCA. Results: Among 1138 pCCA patients included in the study, 826 (73%) had BC type 2 or 3 disease and 312 (27%) had type 4 disease. The two groups demonstrated significant differences in terms of clinicopathologic characteristics (i.e., portal vein embolization, extended hepatectomy, and positive margin). The incidence of severe complications was 46% for the BC types 2 and 3 patients and 51% for the BC type 4 patients (p = 0.1). Moreover, the 90-day mortality was 13% for the BC types 2 and 3 patients and 12% for the BC type 4 patients (p = 0.57). Lymph-node metastasis (N1; hazard-ratio [HR], 1.62), positive margins (R1; HR, 1.36), perineural invasion (HR, 1.53), and poor grade of differentiation (HR, 1.25) were predictors of survival (all p ≤0.004), but BC type was not associated with prognosis. Among the N0 and R0 patients, the 5-year overall survival was 43% for the patients with BC types 2 and 3 pCCA and 41% for those with BC type 4 pCCA (p = 0.60). Conclusions: In this analysis of a large Western multi-institutional cohort, resection was shown to be an acceptable curative treatment option for selected patients with BC type 4 pCCA although a more technically challenging surgical approach was required.
Bismuth; Hepatectomy; Humans; Retrospective Studies; Bile Duct Neoplasms; Cholangiocarcinoma; Klatskin Tumor
Settore MED/18 - Chirurgia Generale
Article (author)
File in questo prodotto:
File Dimensione Formato  
2021-Surgery for Bismuth-Corlette Type 4 Perihilar.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 352.57 kB
Formato Adobe PDF
352.57 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/891997
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 5
social impact